High systemic inflammation as a novel cardiovascular risk factor and target for anti-cytokine therapy: comment regarding the triglyceride glucose index
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Traditional cardiovascular risk factors like high lipids and glucose are insufficient. Systemic inflammation plays a key role in atherosclerotic cardiovascular disease (ASCVD), necessitating new therapeutic targets.
Area Of Science
- Cardiovascular Medicine
- Immunology
- Pharmacology
Background
- Traditional cardiovascular risk factors, including dyslipidemia and diabetes, are well-established but do not fully explain atherosclerosis.
- Emerging research highlights the critical role of the immune system's inflammatory pathways in atherosclerotic cardiovascular disease (ASCVD).
- Both innate (neutrophils, macrophages) and adaptive (T cells, lymphocytes) immune responses contribute to the development of atherosclerosis and atherothrombosis.
Discussion
- Anti-inflammatory therapies targeting immune system modulation, such as anti-cytokine treatments, have shown promise in reducing cardiovascular events.
- The U.S. Food and Drug Administration (FDA) has approved colchicine for cardiovascular event reduction in ASCVD patients with residual inflammation.
- Measuring systemic inflammation is crucial for refining cardiovascular risk assessment.
Key Insights
- Systemic inflammation is a significant contributor to atherosclerotic cardiovascular disease (ASCVD) beyond traditional risk factors.
- Targeting inflammatory pathways with anti-cytokine therapies offers a novel approach to prevent adverse cardiovascular events.
- Identifying patients with high residual inflammation can guide the use of targeted anti-inflammatory treatments.
Outlook
- Further research into inflammatory biomarkers can improve cardiovascular risk stratification.
- Personalized anti-inflammatory strategies may benefit specific patient subsets with ASCVD.
- The integration of inflammatory markers into clinical practice could optimize secondary prevention after ASCVD diagnosis or revascularization.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Overview
In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...